136 related articles for article (PubMed ID: 934519)
1. [Effect of an infusion of piribedil in normal subjects and in patients with peripheral obliterating arterial disease on the blood flow of the lower limbs and on blood, plasma and serum viscosity].
Forconi S; Guerrini M; Agnusdei D; Di Perri T
Minerva Med; 1976 May; 67(25):1671-80. PubMed ID: 934519
[No Abstract] [Full Text] [Related]
2. [Treatment with piribedil in peripheral arterial diseases].
Gatta L; Corti G; Bernasconi S
Minerva Med; 1976 May; 67(25):1668-70. PubMed ID: 778669
[No Abstract] [Full Text] [Related]
3. [Double-blind study on piribedil in peripheral arterial diseases].
Milliken JC; Fares CM; O'Connor D
Minerva Med; 1976 May; 67(25):1662-7. PubMed ID: 778668
[No Abstract] [Full Text] [Related]
4. [Action of dopamine on blood flow of the limbs and on blood viscosity (author's transl)].
Forconi S; Guerrini M; Agnusdei D; Di Perri T
G Ital Cardiol; 1976; 6(5):968-9. PubMed ID: 1010226
[TBL] [Abstract][Full Text] [Related]
5. [Effect of a transient intravenous infusion of isozsuprin on the peripheral blood flow in patients suffering from arterial occlusive disease of the limbs. A contribution to the effect of systemically-administered vasoactive drugs].
Ehringer H; Scheiber V
Wien Klin Wochenschr; 1972 Dec; 24(50):801-8. PubMed ID: 4642105
[No Abstract] [Full Text] [Related]
6. [Piribedil in arterial diseases].
Cristol R; Arnaud F
Nouv Presse Med; 1974 Nov 30-Dec 14; 3(41-43):2573-4. PubMed ID: 4619431
[No Abstract] [Full Text] [Related]
7. [Flowmetric, thermometric and rheologic studies in obliterating arterial diseases of the lower extremities treated with buflomedil].
Dorigo B; Raspanti D; Trapani M; Albanese B; Cameli AM; Digiesi V
Minerva Med; 1985 Feb; 76(7):269-75. PubMed ID: 3974940
[TBL] [Abstract][Full Text] [Related]
8. [Objective data on the action of piribedil in disorders of the peripheral arterial circulation].
Royer RJ
Minerva Med; 1976 May; 67(25):1656-61. PubMed ID: 778667
[No Abstract] [Full Text] [Related]
9. Action of cinnarizine on the blood flow of the lower limbs in patients affected by obliterative peripheral arterial disease and in normal subjects.
Forconi S; Guerrini M; Di Perri T
Vasa; 1976; 5(4):360-5. PubMed ID: 1007545
[No Abstract] [Full Text] [Related]
10. The effect of Prodectin (pyridinolcarbamate) treatment of the circulation rate in obliterating arterial diseases of the lower extremities.
Fényes G; Gótzy G; Fehrentheil L
Ther Hung; 1975; 23(2):64-66. PubMed ID: 1188705
[No Abstract] [Full Text] [Related]
11. Vascular effect of prostaglandin (PGE1) infused into the femoral artery in normals and patients with occlusive arterial disease.
Nielsen PE; Holstein P; Nielsen SL; Poulsen HL
Bibl Anat; 1975; 13():305-6. PubMed ID: 1231765
[No Abstract] [Full Text] [Related]
12. [Effects of pentoxifylline on blood viscosity and peripheral hemodynamics in patients with peripheral occlusive arteriopathies].
Guerrini M; Pecchi S; Rossi C; Cappelli R; Pieragalli D; Acciavatti A
Ric Clin Lab; 1981; 11 Suppl 1():265-79. PubMed ID: 7188114
[No Abstract] [Full Text] [Related]
13. [Piribedil (TF 871) in the treatment of arteriopathies of the lower extremities].
Argenteri A; Moia R; Negri L
Ann Ital Chir; 1979; 51(2):145-55. PubMed ID: 554489
[No Abstract] [Full Text] [Related]
14. Local regulation of subcutaneous blood flow and capillary filtration in limbs with occlusive arterial disease. Studies before and after arterial reconstruction.
Eickhoff JH
Dan Med Bull; 1986 Jun; 33(3):111-26. PubMed ID: 3720362
[TBL] [Abstract][Full Text] [Related]
15. [Intra-arterial infusion therapy in thrombo-obliterating diseases of the lower limbs].
Kurbangaleev SM; Savel'ev IuS
Vestn Khir Im I I Grek; 1974 Oct; 113(10):68-71. PubMed ID: 4432347
[No Abstract] [Full Text] [Related]
16. Segmental blood flow and rheological determinants in diabetic patients with peripheral occlusive arterial disease.
Vigilance JE; Reid HL
J Diabetes Complications; 2008; 22(3):210-6. PubMed ID: 18413225
[TBL] [Abstract][Full Text] [Related]
17. [Regional hemodynamic changes induced by muscular exercise in subjects with obliterating arteriopathy of the lower extremities: effect of beta receptor blocking].
Brevetti G; Paudice G; Lavecchia G; De Caprio L; Ferro G; D'Ascia C; Orefice U
Boll Soc Ital Cardiol; 1977; 22(7):1094-100. PubMed ID: 36115
[No Abstract] [Full Text] [Related]
18. Skin perfusion pressure and cutaneous blood flow in chronic obliterative arterial disease of the lower limbs.
Mirić G; Zdravković M
Acta Med Iugosl; 1988; 42(4):261-8. PubMed ID: 3213561
[No Abstract] [Full Text] [Related]
19. [Cardiopulmonary baroreceptors and peripheral resistance in patients with obliterating arteriopathies of the lower limbs].
De Marchi S; Arosio E; Prior M; Zannoni M; Lucchese L; Lechi A
Minerva Cardioangiol; 1998 Sep; 46(9):313-4. PubMed ID: 10021859
[No Abstract] [Full Text] [Related]
20. [Use of ciclonicate in the treatment of obliterative arteriopathies of the lower limbs].
Licata G; Pinto A; Parrinello G; Salli L; Indovina I
Clin Ter; 1985 Mar; 112(6):503-13. PubMed ID: 4017475
[No Abstract] [Full Text] [Related]
[Next] [New Search]
